Role of positron emission tomography in predicting early tumor response to neoadjuvant chemotherapy for breast cancer

• Main Authors: N. G. Chanchikova (Author), E. A. Karlova (Author), A. S. Savelyeva (Author), O. A. Silkina (Author), V. I. Chernov (Author), R. V. Zelchan (Author), O. D. Bragina (Author), A. A. Medvedeva (Author)
• Format: Book
• Published: ABV-press, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Neoadjuvant chemotherapy (NACT) is an important stage in the treatment of patients with breast cancer. Positron emission tomography/computed tomography (PET/СT) with fluorodeoxyglucose labeled with 18F (18F-FDG) is widely used as an effective method of metabolic tumor imaging at the stag...